Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

of lower loss from operations and higher common shares outstanding due to a public offering of shares of the Company's common stock in the first quarter of 2013, pursuant to which the Company raised net proceeds of approximately $42.7 million through the issuance of 69,696,970 shares of common stock.

As of March 31, 2013, the Company had cash, cash equivalents and short-term investments of $54.4 million, as compared to $24.8 million at December 31, 2012.  The increase in cash was primarily attributable of a public offering of shares of the Company's common stock in first quarter of 2013.  On April 5, 2013, the Company refinanced its long-term debt.  The new long-term debt has a principal amount of $20 million which amortizes at an average monthly cost of approximately $289,000 through October 2016, as compared to approximately $950,000 in monthly debt cost prior to the refinance.

On May 16, 2013 at 11:00 a.m. PDT, Anthera Pharmaceuticals, Inc. will hold its annual shareholder meeting at 1204 Burlingame Avenue #8, Burlingame, CA  94010.  Prior to the meeting the Company encourages all shareholders to cast their votes on proposals presented in the proxy materials. Our Shareholder Letter, Annual Report for the fiscal year ended December 31, 2012, as well as our Proxy Statement for the annual shareholder meeting scheduled for May 16, 2013, are available free of charge on our website at www.anthera.com. Interested parties can request a copy free of charge by calling Investor Relations at 510-856-5600 or sending an e-mail request to Investor Relations by accessing our website (www.anthera.com), selecting the "Investors" tab and then selecting "Investor Contact." Please include your contact information with the request.

Following the annual shareholder meeting, the Company will host a conference call on May 20, 2013 at 2:
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , SINGAPORE, and TOKYO , July 28, ... it has appointed Roger Crystal , MD as ... served in the Global Business Development Product Acquisition & ... "Roger,s experience in developing business strategy and partnerships in ... we continue to partner with biotechnology and pharmaceutical companies ...
(Date:7/28/2014)... 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ... its second quarter and year-to-date 2014 financial results on ... U.S. financial markets. The earnings press release will be ... website, www.anipharmaceuticals.com . Arthur S. ... Charlotte C. Arnold , Vice President and Chief Financial ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... AdvaMed 2011: The MedTech Conference -- day ... Abbott, Abiomed, B. Braun Medical, Baxter International Inc., ... MIT MEDRC in Innovation Alley, a showcase of ... sector meet-ups focused on orthopedic, wound management and ...
... 2011 Tengion, Inc. (Nasdaq: TNGN ) today ... its Board of Directors. Mr. Flora brings to Tengion more ... healing and surgical device businesses.  He most recently served as ... Tengion also announced today that Gary Kurtzman, M.D., ...
Cached Medicine Technology:AdvaMed 2011: The MedTech Conference Closing Day Features Life Changing Innovation, Policymaker Addresses 2Tengion Appoints Scott Flora to Board of Directors 2Tengion Appoints Scott Flora to Board of Directors 3Tengion Appoints Scott Flora to Board of Directors 4
(Date:7/28/2014)... Scottsdale, Ariz (PRWEB) July 28, 2014 ... closed on a new camp property in Cornville, ... provides seriously ill children with the opportunity to ... the campers and families. The organization offers a ... ages 6-15 with chronic and life threatening illnesses ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dawn ... including sales, finance, and music. This experience has ... the direction of psychology. Her professional counseling ( ... and court-ordered treatment for offenders in domestic violence. ... Dawning Phoenix, LLC, she enjoys counseling individuals and ...
(Date:7/28/2014)... Thousands of DePuy Pinnacle hip lawsuits ... who were allegedly injured by a metal-on-metal version of ... in U.S. District Court, Northern District of Texas, Bernstein ... July 18, 2014, U.S. District Judge Ed Kinkeade has ... Steering Committee that sought the deposition of a witness ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... are at risk of contracting meningitis because of specific ... to updated recommendations from the largest pediatrician group in ... the potentially deadly infection should continue for adolescents and ... In its first statement on meningococcal vaccines since 2011, ...
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
Breaking Medicine News(10 mins):Health News:Camp Soaring Eagle Announces New Camp Site 2Health News:Camp Soaring Eagle Announces New Camp Site 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Cell's recycling center implicated in division decisions 2
... DALLAS, Feb. 19 Cholesterol-lowering statins, used by ... may falsely indicate thyroid problems, according to researchers ... studies, low serum TSH, and the influence of ... ."These findings could help physicians make quicker, more ...
... experts say , , THURSDAY, Feb. 19 (HealthDay News) -- A ... people with type 2 diabetes, according to a study that ... sites in Canada and the United States. , The participants, ... in diabetes, underwent cognitive tests designed to measure several aspects ...
... EAST PROVIDENCE, R.I., Feb. 19 IlluminOss ... IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, today ... Bone Stabilization System had been performed on a 21 ... metacarpal.With traditional methods of treating fractures, often an incision ...
... Association and nation,s largest animal protection group say taxing ... for pet owners, increased pet abandonment and public health ... California Veterinary Medical Association (CVMA) and The Humane Society ... the California Legislature for responding to the public,s opposition ...
... Kovalic & Timothy Ogata Join Leading Private Telemedicine ... Call, Inc. (SOC) a leading private telemedicine company ... has completed the expansion of its senior management ... fastest growing provider of telemedical consultations to hospital ...
... a Champion for BabiesNEW YORK, Feb. 19 The March of ... MVP, Eli Manning , will return for a second year, ... Manning will be joined by CBS 2 News Co-Anchor, Maurice ... , who will co-host the morning program. "I,m very excited to ...
Cached Medicine News:Health News:Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems 2Health News:Out-of-Control Blood Sugar May Affect Memory 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 2Health News:IlluminOss Announces First Human Case Utilizing Its Innovative Photodynamic Bone Stabilization System Technology 3Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 2Health News:Pet Owners Avoid a Tax on Their Pet's Health Care in California's Budget 3Health News:Specialists On Call Expands Senior Management & Sales Teams 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: